Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · 4-HO-MET

4-HO-MET in Dominica: not individually verified

Also known as: metocin

Not individually verified

We have not confirmed that 4-HO-MET specifically is scheduled in Dominica, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. No entry for 4-HO-MET was found in Part I, Part II or Part III of the Third Schedule to the Drugs (Prevention of Misuse) Act, Chapter 40:07, on a reading of the three complete printed lists as page images at the revision note «L.R.O. 1/1991» printed in the footer of those pages. The nearest printed entry is the Class A «Pislocin», quoted as the revised edition sets it and read as psilocin, which is the 4-hydroxytryptamine the Schedule does carry. 4-HO-MET shares the 4-hydroxy position but differs at both nitrogen substituents, carrying a methyl and an ethyl where psilocin carries two methyls. So it is neither that substance nor, unlike psilocybin and 4-AcO-DMT, an ester of it, and Part I paragraph 3 is the only derivative route on offer. The absence is bounded by that revision and by nothing further: section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, Orders of that kind are published separately, and this consolidation reproduces none made after the note its Schedule pages carry. So about thirty five years of possible additions sit outside what was read, and that gap is why this row is left open here rather than published as a finding that the substance is uncontrolled in Dominica. Read on 3 October 2026 and not noted on this row before: the Drugs (Prevention of Misuse) Regulations printed in this Chapter carry, in paragraph 1(b) of their Fourth Schedule on printed page 59, a generic clause reaching any compound, other than a named entry, «structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent»; the printed paragraph repeats part of its own opening words, and the passage quoted is its complete final form. 4-HO-MET, 4-hydroxy-N-methyl-N-ethyltryptamine, is a ring-hydroxytryptamine substituted at the side chain nitrogen with a methyl and an ethyl group and nothing else, so it falls within those words. That does not make it a controlled drug. Section 4(1)(a) of the Act defines a controlled drug by Parts I to III of the Act's own Third Schedule, which prints no generic clause of this kind, and the four Schedules to the Regulations sort drugs for the purposes the Regulations name, the Fourth Schedule for regulations 17, 18 and 21 on registers and destruction; they do not add to the list. The same Fourth Schedule names «4-Bromo-2,5-dimethoxy-x-methylphenthylamine», which the Act's Part I does not print, so the Regulations name compounds the printed Act does not; whether that is because the Act was amended or because the Regulations follow a model text never matched to the Act is not shown by either. That mismatch is a further reason to ask whether the Third Schedule was amended in a way this consolidation does not show, and it is why this row stays open rather than being published either way. Where earlier sentences in this cell say the Schedule carries no generic clause, they speak of the Act's Third Schedule and remain accurate.

Confirm directly with Dominica’s national drug authority or your own embassy before you rely on anything.

What Dominica HAS confirmed for related substances

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.